FBLG CIK: 1958777

FibroBiologics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.58
FY22:
−4.47
FY23:
−8.89
FY24:
−13.7
FY25:
−16.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.58
FY22:
−4.37
FY23:
−15.9
FY24:
−16.3
FY25:
−18.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.58
FY22:
−5.12
FY23:
−16.5
FY24:
−11.2
FY25:
−18.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.58
FY22:
−5.12
FY23:
−16.5
FY24:
−11.2
FY25:
−18.6

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data